OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2017
(3)
2015
(2)
2021
(1)
2020
(1)
2018
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival.
Not available
S-EPMC5681448
|
biostudies-literature
Cite
Association between Low Dietary Protein Intake and Geriatric Nutrition Risk Index in Patients with Chronic Kidney Disease: A Retrospective Single-Center Cohort Study.
Not available
S-EPMC5084048
|
biostudies-literature
Cite
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications.
Not available
S-EPMC5681897
|
biostudies-literature
Cite
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.
Not available
S-EPMC5581671
|
biostudies-literature
Cite
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma.
Not available
S-EPMC5871539
|
biostudies-literature
Cite
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.
Not available
S-EPMC4667922
|
biostudies-literature
Cite
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Not available
S-EPMC6883144
|
biostudies-literature
Cite
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.
Not available
S-EPMC4609232
|
biostudies-literature
Cite
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Not available
S-EPMC8811537
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets